Dependence of in vitro-in vivo correlation analysis acceptability on model selections

Pharmaceutical Development and Technology

Volumn 4, Issue 1, 1999, Pages 89-96

  Polli, James E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Dissolution; Human; In vitro in vivo correlation; Metoprolol; Pharmacokinetics

Indexed keywords

METOPROLOL;

AREA UNDER THE CURVE; ARTICLE; CORRELATION FUNCTION; DISSOLUTION; DRUG SOLUBILITY; PRIORITY JOURNAL; TABLET FORMULATION;

BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; METOPROLOL; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SOLUBILITY; TABLETS;

EID: 0032966381     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-100101343     Document Type: Article

References (12)

1. M. Uchiyama, Prospect of drug product quality - regulatory considerations, Proc. Int. Symp. Controlled Release Bioact. Mater., 23, 63-63 (1996).
2. Extended Release Solid Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations, Center for Drug Evaluation and Research, Food and Drug Administration, September, 1997.
3. J. G. Wagner, Do you need a pharmacokinetic model, and, if so, which one?, J. Pharmacokin. Biopharm., 3, 457-478 (1975).
4. G. S. Rekhi, N. E. Eddington, M. J. Fossler, P. Schwartz, L. J. Lesko, and L. L. Augsburger, Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations, Pharm. Dev. Technol., 2, 11-24 (1997).
5. J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah, Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets, J. Pharm. Sci. 86, 690-700 (1997).
6. United States Pharmacopeia, NF 18, 23rd ed., United States Pharmacopeial Convention, Inc., Rockville, MD, 1994.
7. H. Akaike, An Information Criterion (AIC), Math. Sci., 14, 5-9 (1976).
8. J. E. Polli, J. R. Crison, and G. L. Amidon, Novel approach to the analysis of in vitro-in vivo relationships, J. Pharm. Sci., 85, 753-760 (1996).
9. J. E. Polli, Analysis of in vitro-in vivo data, in Scientific Foundations for Regulating Drug Product Quality (G. L. Amidon, J. R. Robinson, and R. L. Williams, eds.), AAPS Press, Alexandria, VA, pp. 335-351 (1997).
10. J. E. Polli and M. J. Ginski, Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities, Pharm. Res., 15, 47-52 (1998).
11. R. E. Madsen, U.S. v. Barr Laboratories: a technical perspective, PDA J. Pharm. Sci. Technol., 48, 176-179 (1994).
12. D. B. Barr and G. R. Dolecek, Out-of-specification laboratory results in the production of pharmaceuticals, Pharm. Technol., 20, 54-60 (1996).